S-1

tegafur/gimeracil/oteracil · Taiho Oncology, Inc.

Drug timelines are a Plus or Pro feature.

289 regulatory and trial events tracked for S-1, covering 2007-07-25 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]

See pricing